Prabhat Singh

@subharti.org

Associate Professor, Faculty of Pharmacy
Swami Vivekanand Subharti University

Prabhat Singh


               Download Compact PDF  
https://researchid.co/prabhat_509

EDUCATION

PhD in Pharmacy

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmacology (medical), Pharmacology, Toxicology and Pharmaceutics, Experimental and Cognitive Psychology
26

Scopus Publications

386

Scholar Citations

11

Scholar h-index

11

Scholar i10-index

Scopus Publications

  • Sodium Alginate Offers Neuroprotection via Mitigating Inflammatory and Oxidative Markers in Cadmium-exposed Experimental Albino Rats
    Prince, Surbhi Gupta, Prabhat Singh, Sachin Tyagi, Bhupesh Sharma, Vikram Singh
    Journal of Pharmaceutical Innovation, 2026
  • AMELIORATIVE EFFECTS OF SELECTIVE PDE-10 INHIBITORS AGAINST KETAMINE-MEDIATED SCHIZOPHRENIC OUTCOMES IN MICE
    RUCHIKA SRIVASTAVA, PRABHAT SINGH, AJEET
    Asian Journal of Pharmaceutical and Clinical Research, 2026
    Objectives: Schizophrenia (SCZ) is characterized by significant impairments in perception and cognitive flexibility. Making accurate plans for therapy demands a deeper comprehension of the brain mechanisms behind these disorders. The purpose of our investigation is to analyze the protective effects of papaverine, a phosphodiesterase-10 inhibitor, on ketamine-induced SCZ -like behavioral and biochemical alterations in mice. Methods: For 10 consecutive days, mice were exposed to ketamine (30 mg/kg; i.p.) to develop a SCZ-like phenotype. Various behavioral tests, including social interactions, catalepsy, cognitive impairment (Morris water maze), locomotor and anxiety (open field test), and immobility duration (forced swim test), were assessed. Biochemicals (acetylcholinesterase [AChE] activity, glutathione, and lipid peroxides), and histopathological alterations were also investigated. In this study, papaverine (30 mg/kg; i.p.) and clozapine (7.5 mg/kg p.o.) served as test and standard, respectively. Results were statistically analyzed and “one-way ANOVA” was performed, and Tukey’s multiple comparison test was subsequently applied.” Results: After 28 days of ketamine therapy, significant (p≤0.05) behavioral alterations have been noted, including increased immobility duration, altered locomotor and anxiety-like behaviors, social interactions, cognitive impairment, and catalepsy. Significant alterations in histopathology, AChE activity, and oxidative stress (increased lipid peroxides and lower glutathione) were also observed in mice treated with ketamine. Treatment with clozapine and papaverine considerably (p≤0.05) improved the biochemical changes, behavioral problems, and histological changes. Conclusion: We may conclude that papaverine may have neurodefensive effects against ketamine-induced SCZ in mice based on behavioral, histological, and biochemical observations.
  • Neurodegeneration and synaptic impairments mediated by chronic light-induced circadian rhythm and molecular signaling disruption: an insight beyond vision
    Rajat Dumka, Prabhat Singh, Vishal Biswkarma, Lubhan Singh, Swati Wadhawan
    Biological Rhythm Research, 2026
    Light not only provides visual information but also constitutes a powerful modulator of non-visual functions, including improvement of alertness and performance on several cognitive tasks. Over the last two decades, growing evidence has also shown that exposure to light from artificial sources is considered a pollutant for human health. The objective of this review is to update researchers in understanding the role of chronic light exposure and the mechanisms involved in neurological alteration. This review focuses on the role of lighting conditions in affecting non-visual consequences, especially the brain (learning and memory). The mechanistic approaches have been included and explained how chronic light induces neurological alterations in animal models. The review highlighted the impact and evidence of therapeutic alternatives evaluated and paucities in the management of neurodegenerative changes caused by chronic light exposure in preclinical studies. Beyond vision, the findings of the literature review indicated that chronic light exposure with different types, intensities, and exposure times leads to neurodegeneration and synaptic impairments via circadian rhythm and molecular signaling alterations. As for management, there are still many paucities. So, it becomes a major area for studies to be conducted as light pollution is increasing at its peak.
  • Cerebroprotective potential of ceftriaxone against cadmium chloride-induced cerebral inflammatory changes and oxidative insult
    Mansi Chaudhary, Prabhat Singh, Surbhi Gupta, Vishal Kumar Biswkarma, Priyadarshini Soni, Lubhan Singh
    Naunyn Schmiedeberg S Archives of Pharmacology, 2026
  • Agonism of MT1 and MT2 Receptor Mitigates Oxidative Insult, Neuroinflammation, and Cerebral Injury in Cadmium Chloride Treated Animals
    Mani Singh Jadaun, Prabhat Singh, Surbhi Gupta
    Neurochemical Research, 2025
  • EXPLORING THE ANTIDIABETIC, LIPID-LOWERING, AND TISSUE REPAIR BENEFITS OF MULTI-COMPONENT MICROSPHERES IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
    Asian Journal of Pharmaceutical and Clinical Research, 2025
  • Therapeutic applications of rutin for diabetes mellitus and its complications
    Natural Therapeutics for Diabetes Mellitus Medicinal Plants Phytochemicals and Bioactive Compounds, 2025
  • PROTECTIVE EFFECT OF CILOSTAZOL AGAINST KETAMINE-INDUCED BIOCHEMICAL AND BEHAVIORAL PHENOTYPE OF SCHIZOPHRENIA IN MICE
    RUCHIKA SRIVASTAVA, PRABHAT SINGH, AJEET
    Asian Journal of Pharmaceutical and Clinical Research, 2025
    Objective: Schizophrenia (SCZ), a mental illness affecting 1% of the world population, is characterized by extensive structural and functional brain changes. It is brought on by a confluence of psychological, environmental, and hereditary variables. It is frequently coexisted with other diseases, lowering the quality of life and increasing the risk of early death. The objective of this research is to explored the potential of cilostazol (Phosphodiesterase-3 inhibitor) in ketamine (KET)-induced SCZ -like behavioral and biochemical alterations in mice. Methods: In mice, SCZ was induced by injecting KET (30 mg/kg; i.p.) for 10 days in a row. Different behavioral parameters such as immobility time (Forced swim test), locomotor and anxiety (open field test), cognitive dysfunction (Morris water maze), social interactions, and catalepsy were examined. Histopathological and biochemical changes (lipid peroxides, glutathione [GSH], acetylcholinesterase [AChE] activity) were also examined. Cilostazol (25 and 50 mg/kg; p.o.) as a test and clozapine (7.5 mg/kg p.o.), as a standard drug were used in this investigation. Tukey’s multiple comparison test and one-way analysis of variance were used for statistical analysis of all the findings. p<0.050 was regarded as statistically significant. Results: Significant (p<0.05) behavioral changes have been observed following 28 days of KET treatment (increased immobility time, impaired locomotor and anxiety-like behaviors, cognitive dysfunction, social interactions, and catalepsy). Increased oxidative stress (higher lipid peroxides and decreased GSH), AChE activity, and histopathological changes were also noted significantly in KET -treated mice. Cilostazol and clozapine treatment significantly (p<0.05) corrected the histological changes, biochemical alterations, and behavioral problems. Conclusion: As per the behavioral, histopathological, and biochemical outcomes, we can draw a conclusion that cilostazol may provide neurodefensive effects against KET -induced SCZ in mice.
  • Exploring Nature's Pharmacy: A Comprehensive Review of Herbal Plants with Neuroprotective Properties
    Dipesh Prajapati, Prabhat Singh
    Current Green Chemistry, 2025
    Neurodegenerative disorders, such as Alzheimer's, Parkinson's, and Huntington's, are an increasing health concern worldwide due to their progressive nature and limited therapeutic choices. In search of innovative treatment techniques, herbal plants have received considerable attention due to their possible neuroprotective characteristics. For the literature review, several databases are used like Science Direct, PubMed, Springer, Frontiers, MDPI, Wiley, and Elsevier. This article offers a complete assessment of the neuroprotective properties of several herbal plants in preclinical and clinical research. This article discussed the active components, modes of action, and therapeutic potential of selected medicinal plants, including Ginkgo biloba, Bacopa monnieri, Curcuma longa, Panax ginseng, and Withania somnifera. These plants have a variety of neuroprotective properties, including antioxidant, anti-inflammatory, anti-apoptotic, and neurogenesis-promoting properties. Additionally, this review emphasizes the synergistic benefits reported when employing mixtures of these plants or combining them with conventional therapies. Despite encouraging results, existing research is sometimes restricted by small sample numbers, diversity in study designs, and lack of uniform dosing. Future studies should overcome these limitations through well-designed clinical studies and standardized extraction processes to fully understand the neuroprotective potential of these herbal plants. This review emphasizes the importance of incorporating herbal medicines into the development of novel treatments for neurodegenerative illnesses.
  • Cerebroprotective Potential of Androgen Receptors in Ischemic Postconditioning against Cerebral Ischemia/Reperfusion-Induced Neurodegenerative Changes
    Prabhat Singh, Surbhi Gupta, Bhupesh Sharma, Lubhan Singh, Rani Bansal, Mamta Gupta
    Central Nervous System Agents in Medicinal Chemistry, 2025
    Background and Objective: In stroke, reperfusion of blood to the cerebral ischemic area following sustained ischemia further exacerbates tissue damage, identified as cerebral ischemia and reperfusion (I/R) insult. Ischemic post-conditioning (IPoC) appears to offer benefits against I/R injury. The cascade of androgen receptors (ARs) has a vital role in cerebral stroke; however, its neurodefensive function in IPoC is unclear. This investigation aimed to explore the involvement of ARs in IPoC in cerebral I/R insult in rats. Methods: Global cerebral ischemia/reperfusion (GCI/R) insult in experimental animals was provoked by 10 minutes of obstruction of the bilateral carotid arteries after reperfusion for 24 hours. IPoC was carried out by providing a triad of I/R insults with a gap of 10 minutes of GCI after 24 hours of reperfusion. Lateral push, inclined beam, rota rod, hanging wire, and Morris-water maze experimentations were conducted on animals to determine motor control and cognitive functions (learning and memory). Cerebral oxidative damage markers (raised lipid peroxidation and reduced glutathione levels), acetylcholinesterase (AChE) activity, inflammatory indicators (interleukin-6, interleukin-10, tumor necrosis factor-α, and myeloperoxidase), infarction, and histopathological alterations were also assessed. Results: Animals with I/R exhibited reduced motor function and memory along with raised cerebral oxidative damage, AChE activity, inflammation, infarction, and histopathological alterations. IPoC after ischemic events recuperated the damaging outcomes of I/R insult. 60 minutes before cerebral ischemia, pretreatment with testosterone mimicked the neurodefensive outcomes of IPoC. However, neuroprotective outcomes developed by IPoC were diminished by flutamide (ARs antagonist) pretreatment. Conclusion: IPoC may offer neuroprotective outcomes in I/R insult by modulation of ARmediated pathway. result: Animals with I/R exhibited reduced motor function, and memory along with raised cerebral oxidative damage, AChE activity, inflammation, infarction, and histopathological alterations. IPoC after ischemic events recuperated the damaging outcomes of I/R insult. 60 min prior to cerebral ischemia, pretreatment with testosterone mimicked the neurodefensive outcomes of IPoC. Although, neuroprotection developed by IPoC was ended by the flutamide (ARs antagonist) pretreatment.
  • The role of catechins in diabetes and its complications
    Naturally Occurring Chemicals for the Treatment and Management of Diabetes Mellitus and Related Disorders, 2024
  • Rutin in the management of diabetes mellitus
    Naturally Occurring Chemicals for the Treatment and Management of Diabetes Mellitus and Related Disorders, 2024
  • Montelukast Ameliorates 2K1C-Hypertension Induced Endothelial Dysfunction and Associated Vascular Dementia
    Surbhi Gupta, Prabhat Singh, Bhupesh Sharma
    Current Hypertension Reviews, 2024
  • A Comprehensive Review on Molecular Mechanism Involved in Arsenic Trioxide Mediated Cerebral Neurodegenerative and Infectious Diseases
    Vaishali Negi, Prabhat Singh, Lubhan Singh, Rupesh Kumar Pandey, Sokindra Kumar
    Infectious Disorders Drug Targets, 2024
  • Neuroprotective Effect of Chlorogenic Acid against Pentylenetetrazol Induced Kindled Epilepsy in Mice
    Akansha Singh, Lubhan Singh, Rupesh Pandey, Prabhat Singh, Moazzam Ali, Rahul Kaushik, Priyadarshini Soni
    International Journal of Drug Delivery Technology, 2023
  • Neuroprotective Effect of Morinda citrifolia on Behavioural and Biochemical Deficits in PTZ-induced Kindled Mice
    Moazzam Ali, Prabhat Singh, Lubhan Singh, Rupesh Kumar Pandey, Priyadarshini Soni, Akansha Singh
    Infectious Disorders Drug Targets, 2023
  • Pharmacological connection of histamine-1 (H1) receptor mediated neuroprotective mechanism of ischemic preconditioning in rat
    Prabhat Singh, Bhupesh Sharma
    Research Journal of Pharmacy and Technology, 2021
  • Androgen receptor involvement in ischemic preconditioning during cerebral ischemia-reperfusion injury
    International Journal of Pharmaceutical Research, 2020
  • Agonism of histaminergic-h1 receptors in ischemic postconditioning during cerebral ischemia-reperfusion injury is protective
    Prabhat Singh, Bhupesh Sharma
    Current Neurovascular Research, 2020
  • Neuroprotective Effects of Nicorandil in Chronic Cerebral Hypoperfusion-Induced Vascular Dementia
    Surbhi Gupta, Prabhat Singh, Bhupesh Sharma
    Journal of Stroke and Cerebrovascular Diseases, 2016
  • Of Endothelin (ETA and ETB) receptors during renovascular hypertension-induced vascular dementia improves cognition
    Prabhat Singh, Surbhi Gupta, Bhupesh Sharma
    Current Neurovascular Research, 2016
  • Reversal in cognition impairments, cholinergic dysfunction, and cerebral oxidative stress through the modulation of ryanodine receptors (RyRs) and cysteinyl leukotriene-1 (CysLT1) Receptors
    Prabhat Singh, Bhupesh Sharma
    Current Neurovascular Research, 2016
  • Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia
    Surbhi Gupta, Prabhat Singh, Brij Sharma, Bhupesh Sharma
    Current Neurovascular Research, 2015
  • Melatonin receptor and KATP channel modulation in experimental vascular dementia
    Prabhat Singh, Surbhi Gupta, Bhupesh Sharma
    Physiology and Behavior, 2015
  • In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator
    Prabhat Singh, Bhupesh Sharma, Surbhi Gupta, B. M. Sharma
    Psychopharmacology, 2015
  • Modulation of transient receptor potential vanilloid subtype 1 (trpv1) and norepinephrine transporters (net) protect against oxidative stress, cellular injury, and vascular dementia
    Surbhi Gupta, Bhupesh Sharma, Prabhat Singh, Brij Sharma
    Current Neurovascular Research, 2014

RECENT SCHOLAR PUBLICATIONS

  • Ameliorative Effects of Selective PDE-10 Inhibitors Against Ketamine-Mediated Schizophrenic Outcomes in Mice
    A RUCHIKA SRIVASTAVA, PRABHAT SINGH *
    AJPCR (Asian J Pharm Clin Res) 19 (1), 120-127 , 2026
    2026
  • Sodium Alginate Offers Neuroprotection via Mitigating Inflammatory and Oxidative Markers in Cadmium-exposed Experimental Albino Rats
    BSVS Prince, Surbhi Gupta, Prabhat Singh, Sachin Tyagi
    Journal of Pharmaceutical Innovation 21 , 2026
    2026
  • Cerebroprotective potential of ceftriaxone against cadmium chloride-induced cerebral inflammatory changes and oxidative insult
    LS Mansi Chaudhary, Prabhat Singh *, Surbhi Gupta, Vishal Kumar Biswkarma ...
    Naunyn-Schmiedeberg's Archives of Pharmacology , 2026
    2026
  • Neurodegeneration and synaptic impairments mediated by chronic light-induced circadian rhythm and molecular signaling disruption: an insight beyond vision
    R Dumka, P Singh, V Biswkarma, L Singh, S Wadhawan
    Biological Rhythm Research , 2026
    2026
  • Therapeutic Strategies for Ovariectomy-InducedVascular Dementia: Current Insights and Future Directions
    PS Ankit Sharma
    International Journal of Environmental Sciences 11 (23s), 937-946 , 2025
    2025
  • Current and Traditional Approaches to Polycystic Ovarian Syndrome Treatment: A Review
    P Munday, P Singh*
    Current Indian Science , 2025
    2025
  • Exploring Nature's Pharmacy: A Comprehensive Review of Herbal Plants with Neuroprotective Properties
    Prajapati Dipesh and Singh Prabhat *
    Current Green Chemistry 12 , 2025
    2025
    Citations: 5
  • Agonism of MT1 and MT2 Receptor Mitigates Oxidative Insult, Neuroinflammation, and Cerebral Injury in Cadmium Chloride Treated Animals
    SG Jadaun Mani Singh, Singh Prabhat *
    Neurochemical Research , 2025
    2025
    Citations: 7
  • Cerebroprotective Potential of Androgen Receptors in Ischemic Postconditioning against Cerebral Ischemia/Reperfusion-Induced Neurodegenerative Changes
    S Prabhat, G Surbhi, B Sharma, L Singh, R Bansal, M Gupta
    Central nervous system agents in medicinal chemistry 26 (2), 183-200 , 2025
    2025
    Citations: 3
  • Exploring the Antidiabetic, Lipid-Lowering, and Tissue Repair Benefits of Multi-Component Microspheres in Streptozotocin-Induced Diabetic Rats
    GP Chauhan, A. , Gupta, S. , Singh, P. , Mishra
    Asian Journal of Pharmaceutical and Clinical Research 18 (5), 91-95. , 2025
    2025
  • Therapeutic applications of rutin for diabetes mellitus and its complications
    AS Prabhat Singh, Surbhi Gupta, Charu Bharti
    Natural Therapeutics for Diabetes Mellitus: Medicinal Plants, Phytochemicals … , 2025
    2025
  • Protective Effect of Cilostazol Against Ketamine-Induced Biochemical and Behavioral Phenotype of Schizophrenia in Mice
    A RUCHIKA SRIVASTAVA, PRABHAT SINGH *
    Asian Journal of Pharmaceutical and Clinical Research 18 (4), 230–237 , 2025
    2025
  • Implications of Glutamate Transporter-1 in Neurodegeneration-Associated Cognitive Impairments
    M Chaudhary, S Prabhat *, P Soni, L Singh, RK Pandey, S Gupta
    African Journal of Biological Sciences 6 (10), 7169-7181 , 2024
    2024
  • Calcium Channels: A Potential Therapeutic Target for Schizophrenia
    A Ruchika Srivastava, Prabhat Singh*
    African Journal of Biological Sciences 6 (10), 6964-6974 , 2024
    2024
  • A comprehensive review on molecular mechanism involved in arsenic trioxide mediated cerebral neurodegenerative and infectious diseases
    V Negi, P Singh, L Singh, RK Pandey, S Kumar
    Infectious Disorders-Drug TargetsDisorders) 24 (3), 51-59 , 2024
    2024
    Citations: 7
  • The Role of Catechins in Diabetes and Its Complications
    BS Surbhi Gupta1, Prabhat Singh2, Vaishali Negi2
    Naturally Occurring Chemicals for the Treatment and Management of Diabetes … , 2024
    2024
  • Rutin in the Management of Diabetes Mellitus
    CB Prabhat Singh3, Jyoti1, Meena Devi1, Nisham Rani1, Ritu Kataria1, Dev Raj ...
    Naturally Occurring Chemicals for the Treatment and Management of Diabetes … , 2024
    2024
  • Montelukast ameliorates 2K1C-hypertension induced endothelial dysfunction and associated vascular dementia
    S Gupta, P Singh, B Sharma
    Current Hypertension Reviews 20 (1), 23-35 , 2024
    2024
    Citations: 7
  • Neuroprotective Effect of Morinda citrifolia on Behavioural and Biochemical Deficits in PTZ-induced Kindled Mice
    M Ali, P Singh, L Singh, RK Pandey, P Soni, A Singh
    Infectious Disorders-Drug TargetsDisorders) 23 (8), 30-42 , 2023
    2023
    Citations: 9
  • Vitamin-D attenuates chronic unpredictable mild stress induced depression like behavior in rats
    Priyadarshini Soni, Prabhat Singh, Lubhan Singh, Moazzam Ali, Akansha Singh
    European Chemical Bulletin 12 (9), 2384-2398 , 2023
    2023

MOST CITED SCHOLAR PUBLICATIONS

  • Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia
    S Gupta, P Singh, B Mohan Sharma, B Sharma
    Current Neurovascular Research 12 (3), 240-252 , 2015
    2015
    Citations: 77
  • Melatonin receptor and KATP channel modulation in experimental vascular dementia
    P Singh, S Gupta, B Sharma
    Physiology & behavior 142, 66-78 , 2015
    2015
    Citations: 47
  • Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular …
    S Gupta, B Sharma, P Singh, B Mohan Sharma
    Current neurovascular research 11 (2), 94-106 , 2014
    2014
    Citations: 45
  • Neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia
    S Gupta, P Singh, B Sharma
    Journal of Stroke and Cerebrovascular Diseases 25 (11), 2717-2728 , 2016
    2016
    Citations: 28
  • Reversal in cognition impairments, cholinergic dysfunction, and cerebral oxidative stress through the modulation of ryanodine receptors (RyRs) and cysteinyl leukotriene-1 …
    P Singh, B Sharma
    Current neurovascular research 13 (1), 10-21 , 2016
    2016
    Citations: 26
  • Selective serotonin-norepinephrine re-uptake inhibition limits renovas-cular-hypertension induced cognitive impairment, endothelial dysfunction, and oxidative stress injury
    P Singh, B Sharma
    Current Neurovascular Research 13 (2), 135-146 , 2016
    2016
    Citations: 25
  • In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective K ATP channel modulator
    P Singh, B Sharma, S Gupta, BM Sharma
    Psychopharmacology 232 (2), 465-475 , 2015
    2015
    Citations: 22
  • Plant bioactive compounds and their mechanistic approaches in the treatment of diabetes: a review
    Anshika, RK Pandey, L Singh, S Kumar, P Singh, M Pathak, S Jain
    Future Journal of Pharmaceutical Sciences 8 (1), 52 , 2022
    2022
    Citations: 20
  • Antagonism of endothelin (ETA and ETB) receptors during renovascular hypertension-induced vascular dementia improves cognition.
    P Singh, S Gupta, B Sharma
    Current neurovascular research 13 (3), 219-229 , 2016
    2016
    Citations: 15
  • Agonism of histaminergic-H1 receptors in ischemic postconditioning during cerebral ischemia-reperfusion injury is protective.
    P Singh, B Sharma
    Current Neurovascular Research , 2020
    2020
    Citations: 14
  • Antiepileptic activity of aqueous extract of Tricosanthes dioica Roxb
    SG Prabhat Singh, Vipin K Garg, Pramod K Sharma
    Asian Journal of Plant Science and Research 2 (1), 45-47 , 2012
    2012
    Citations: 12
  • Neuroprotective Effect of Morinda citrifolia on Behavioural and Biochemical Deficits in PTZ-induced Kindled Mice
    M Ali, P Singh, L Singh, RK Pandey, P Soni, A Singh
    Infectious Disorders-Drug TargetsDisorders) 23 (8), 30-42 , 2023
    2023
    Citations: 9
  • Phytochemical constituents and pharmacological activities, profile of Morinda citrifolia: A review
    M Ali, P Singh, L Singh, S Kumar
    World J. Pharm. Res 9, 421-433 , 2020
    2020
    Citations: 9
  • Agonism of MT1 and MT2 Receptor Mitigates Oxidative Insult, Neuroinflammation, and Cerebral Injury in Cadmium Chloride Treated Animals
    SG Jadaun Mani Singh, Singh Prabhat *
    Neurochemical Research , 2025
    2025
    Citations: 7
  • A comprehensive review on molecular mechanism involved in arsenic trioxide mediated cerebral neurodegenerative and infectious diseases
    V Negi, P Singh, L Singh, RK Pandey, S Kumar
    Infectious Disorders-Drug TargetsDisorders) 24 (3), 51-59 , 2024
    2024
    Citations: 7
  • Montelukast ameliorates 2K1C-hypertension induced endothelial dysfunction and associated vascular dementia
    S Gupta, P Singh, B Sharma
    Current Hypertension Reviews 20 (1), 23-35 , 2024
    2024
    Citations: 7
  • Exploring Nature's Pharmacy: A Comprehensive Review of Herbal Plants with Neuroprotective Properties
    Prajapati Dipesh and Singh Prabhat *
    Current Green Chemistry 12 , 2025
    2025
    Citations: 5
  • Cerebroprotective Potential of Androgen Receptors in Ischemic Postconditioning against Cerebral Ischemia/Reperfusion-Induced Neurodegenerative Changes
    S Prabhat, G Surbhi, B Sharma, L Singh, R Bansal, M Gupta
    Central nervous system agents in medicinal chemistry 26 (2), 183-200 , 2025
    2025
    Citations: 3
  • Pharmacological connection of Histamine-1 (H1) Receptor Mediated Neuroprotective mechanism of Ischemic preconditioning in rat
    P Singh, B Sharma
    Research Journal of Pharmacy and Technology 14 (5), 2717-2722 , 2021
    2021
    Citations: 3
  • Review of Experimental Models of Schizophrenia
    RAB Bushra Naz,Prabhat Singh, Simon Nyarko
    International Neuropsychiatric Disease Journal 19 (1), 1 - 19 , 2023
    2023
    Citations: 2